大幸薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2014/08/14 | 1,671 | 1,698 | 1,663 | 1,684 | -4 | -0.2% | 144,700 |
| 2014/08/13 | 1,565 | 1,728 | 1,565 | 1,688 | +134 | +8.6% | 743,600 |
| 2014/08/12 | 1,645 | 1,653 | 1,551 | 1,554 | -99 | -6% | 411,700 |
| 2014/08/11 | 1,694 | 1,694 | 1,635 | 1,653 | -1 | -0.1% | 147,700 |
| 2014/08/08 | 1,764 | 1,768 | 1,620 | 1,654 | -110 | -6.2% | 317,300 |
| 2014/08/07 | 1,678 | 1,787 | 1,678 | 1,764 | +102 | +6.1% | 510,700 |
| 2014/08/06 | 1,690 | 1,697 | 1,660 | 1,662 | -42 | -2.5% | 140,800 |
| 2014/08/05 | 1,688 | 1,719 | 1,679 | 1,704 | +34 | +2% | 217,500 |
| 2014/08/04 | 1,645 | 1,678 | 1,645 | 1,670 | +25 | +1.5% | 69,100 |
| 2014/08/01 | 1,651 | 1,669 | 1,640 | 1,645 | -11 | -0.7% | 91,600 |
| 2014/07/31 | 1,670 | 1,676 | 1,651 | 1,656 | -7 | -0.4% | 110,800 |
| 2014/07/30 | 1,671 | 1,681 | 1,659 | 1,663 | -19 | -1.1% | 96,400 |
| 2014/07/29 | 1,655 | 1,689 | 1,654 | 1,682 | +33 | +2% | 188,600 |
| 2014/07/28 | 1,635 | 1,653 | 1,626 | 1,649 | +22 | +1.4% | 72,400 |
| 2014/07/25 | 1,611 | 1,630 | 1,604 | 1,627 | +23 | +1.4% | 74,200 |
| 2014/07/24 | 1,614 | 1,627 | 1,587 | 1,604 | -3 | -0.2% | 72,400 |
| 2014/07/23 | 1,608 | 1,624 | 1,603 | 1,607 | -1 | -0.1% | 39,800 |
| 2014/07/22 | 1,606 | 1,619 | 1,604 | 1,608 | +2 | +0.1% | 42,900 |
| 2014/07/18 | 1,608 | 1,610 | 1,591 | 1,606 | -18 | -1.1% | 48,100 |
| 2014/07/17 | 1,643 | 1,650 | 1,613 | 1,624 | -19 | -1.2% | 85,600 |
| 2014/07/16 | 1,649 | 1,660 | 1,639 | 1,643 | -6 | -0.4% | 84,100 |
| 2014/07/15 | 1,649 | 1,658 | 1,637 | 1,649 | +5 | +0.3% | 114,600 |
| 2014/07/14 | 1,596 | 1,648 | 1,596 | 1,644 | +53 | +3.3% | 154,800 |
| 2014/07/11 | 1,607 | 1,616 | 1,572 | 1,591 | -30 | -1.9% | 177,500 |
| 2014/07/10 | 1,626 | 1,629 | 1,616 | 1,621 | -1 | -0.1% | 84,400 |
| 2014/07/09 | 1,623 | 1,628 | 1,606 | 1,622 | -2 | -0.1% | 115,100 |
| 2014/07/08 | 1,638 | 1,638 | 1,619 | 1,624 | -14 | -0.9% | 117,200 |
| 2014/07/07 | 1,628 | 1,640 | 1,618 | 1,638 | +28 | +1.7% | 190,600 |
| 2014/07/04 | 1,611 | 1,629 | 1,605 | 1,610 | +2 | +0.1% | 140,700 |
| 2014/07/03 | 1,580 | 1,608 | 1,580 | 1,608 | +34 | +2.2% | 250,700 |
| 2014/07/02 | 1,560 | 1,576 | 1,556 | 1,574 | +26 | +1.7% | 162,700 |
| 2014/07/01 | 1,550 | 1,555 | 1,534 | 1,548 | ±0 | ±0% | 156,800 |
| 2014/06/30 | 1,540 | 1,551 | 1,523 | 1,548 | -3 | -0.2% | 194,000 |
| 2014/06/27 | 1,561 | 1,561 | 1,527 | 1,551 | -3 | -0.2% | 145,400 |
| 2014/06/26 | 1,540 | 1,562 | 1,540 | 1,554 | +13 | +0.8% | 92,900 |
| 2014/06/25 | 1,551 | 1,556 | 1,541 | 1,541 | -6 | -0.4% | 71,800 |
| 2014/06/24 | 1,550 | 1,559 | 1,534 | 1,547 | +4 | +0.3% | 91,000 |
| 2014/06/23 | 1,541 | 1,558 | 1,534 | 1,543 | +2 | +0.1% | 92,500 |
| 2014/06/20 | 1,553 | 1,555 | 1,535 | 1,541 | -9 | -0.6% | 104,800 |
| 2014/06/19 | 1,558 | 1,560 | 1,546 | 1,550 | +5 | +0.3% | 142,300 |
| 2014/06/18 | 1,525 | 1,546 | 1,515 | 1,545 | +20 | +1.3% | 167,400 |
| 2014/06/17 | 1,500 | 1,525 | 1,486 | 1,525 | +36 | +2.4% | 138,700 |
| 2014/06/16 | 1,517 | 1,527 | 1,481 | 1,489 | -18 | -1.2% | 194,300 |
| 2014/06/13 | 1,465 | 1,510 | 1,464 | 1,507 | +35 | +2.4% | 189,600 |
| 2014/06/12 | 1,455 | 1,478 | 1,442 | 1,472 | +16 | +1.1% | 192,200 |
| 2014/06/11 | 1,461 | 1,472 | 1,453 | 1,456 | -9 | -0.6% | 198,900 |
| 2014/06/10 | 1,470 | 1,484 | 1,460 | 1,465 | -8 | -0.5% | 229,600 |
| 2014/06/09 | 1,480 | 1,484 | 1,471 | 1,473 | -7 | -0.5% | 204,400 |
| 2014/06/06 | 1,482 | 1,493 | 1,466 | 1,480 | -2 | -0.1% | 187,100 |
| 2014/06/05 | 1,527 | 1,529 | 1,462 | 1,482 | -45 | -2.9% | 353,700 |
2651～
2700
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大幸薬品 | 36,700円 | +0.1% | -70.9% | 0.00% | 61.37倍 | 2.31倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ステムリム | 32,600円 | - | - | 0.00% | - | 3.00倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 扶桑薬 | 210,200円 | +1.6% | -12.7% | 4.28% | 7.81倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ＣＡＮＢＡＳ | 96,600円 | - | - | 0.00% | - | 6.18倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| キッズバイオ | 37,000円 | - | - | 0.00% | - | 13.17倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム
